The use of intermittent scanning continuous glucose monitoring improves glycaemic control outcomes in older adult patients ...

In type 1 diabetes, the body’s own immune system turns against the pancreas. Cells meant to protect you start destroying ...

A pioneering immunotherapy drug to treat type 1 diabetes is soon to be tested on human participants for the first time.

Adults diagnosed with type 1 diabetes face significantly higher risks of heart disease and early death a new study ...

Access to Medicine Foundation report highlights barriers to insulin access for children with type 1 diabetes in low-income ...

Balancing best practices with patient affordability and literacy. Here’s how one doctor adapts treatment plans for real-world ...

The provincial government is expanding the eligibility for the Continuous Glucose Monitoring Program. As of this fall, all ...